Cargando…
MicroRNA-363-3p downregulation in papillary thyroid cancer inhibits tumor progression by targeting NOB1
MicroRNA-363-3 p (miR-363–3 p) has been reported to play a crucial role in tumor development and progression, and function as a tumor suppressor in many types of cancer. In our previous studies, we found that miRNA-363–3 p inhibited papillary thyroid carcinoma (PTC) progression by targeting PIK3CA....
Autores principales: | Dong, Su, Xue, Shuai, Sun, Yue, Han, Zhe, Sun, Lele, Xu, Jialu, Liu, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803892/ https://www.ncbi.nlm.nih.gov/pubmed/33077486 http://dx.doi.org/10.1136/jim-2020-001562 |
Ejemplares similares
-
MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
por: Lin, Yang, et al.
Publicado: (2017) -
Retraction: MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
por: Lin, Yang, et al.
Publicado: (2023) -
Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
por: Liu, Jia, et al.
Publicado: (2022) -
[Retracted] MicroRNA‑744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1
por: Liu, Haixia, et al.
Publicado: (2023) -
MicroRNA‐612 inhibits cervical cancer progression by targeting NOB1
por: Jin, Yang, et al.
Publicado: (2020)